HNHarish Narayanan

Harish Narayanan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Harish Narayanan has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cortisol Levels and Their Association with Workplace Stress in IT Workers

    by Harish Narayanan, Shankar K, Shenbaga Lalitha Shankar, ShanmugaPriya K, Pm Anbumaran, Rajarajeswaran Krishnan

    Background: Workplace stress is increasingly recognized as a physiological and psychological burden in cognitively demanding occupations such as information technology. Chronic stress activates the hypothalamic-pituitary-adrenal (HPA) axis and can lead to cortisol dysregulation, measurable through serum biomarkers. Objectives: To evaluate the association between workplace stress and diurnal serum cortisol levels among IT professionals in Chennai, India. Methods: A cross-sectional study was conducted involving 300 full-time IT professionals aged 25 to 45 years. Participants completed the Health and Safety Executive (HSE) Management Standards Indicator Tool to assess occupational stress across seven domains. Serum cortisol was measured via chemiluminescent immunoassay at two-time points morning (8–9 AM) and evening (6–7 PM) to evaluate diurnal variation. Associations were analyzed using correlation and multivariate regression, adjusting for age, gender, BMI, and smoking. Results: Mean cortisol levels were higher in the morning (418.3 ± 96.4 nmol/L) than evening (211.7 ± 85.2 nmol/L). A flattened diurnal rhythm, defined as a morning–evening cortisol difference of less than 150 nmol/L, was observed in 22% of participants. Lower scores in job control, role clarity, and workplace relationships were significantly associated with cortisol dysregulation. Female gender and smoking were additional risk factors. Conclusions: Serum cortisol alterations reflect psychosocial stress exposure. Diurnal cortisol assessment may serve as a useful biomarker of work-related stress, supporting the need for organizational interventions.


  • Open Access

    Current and Prospective Biochemical Markers for the Identification of Acute Coronary Syndrome-A Review

    by Rama Rao Nadendla, Harish Narayanan, Roopa Murgod, Khalid Suliman Alboloi, Maya Savira, Pichandy Muthuprasanna

    Acute coronary syndrome (ACS) represents a spectrum of heart muscle oxygen deprivation (ischemia) which ranges from temporary tissue damage in angina to unstable angina with possible minor cell death and finally to a full-blown heart attack (myocardial infarction) with extensive tissue necrosis. Biochemical indicators of damage to the heart muscle remain crucial in the comprehensive evaluation and management of individuals with various forms of ACS. Diagnosing ACS accurately is crucial for optimal treatment. While existing biochemical markers play a vital role, searching for an ideal biomarker continues. Biochemical markers of myocardial injury are critical for the global assessment and treatment of individuals with these syndromes. The objective of the review, is to primarily evaluate the current understanding of ACS biomarkers rather than specifically to assess which biomarkers are most promising. The review emphasizes the importance of existing biochemical markers, the ongoing search for an ideal biomarker, and how these markers are crucial for the diagnosis and management of ACS. This review examines various biochemical markers associated with atherosclerosis, including matrixins, PAPP-A metalloproteinase, myeloperoxidase, microalbuminuria, cystatin, P-selectin, glycogen phosphorylase-BB, C-reactive protein marker, cluster of differentiation 40 (CD40L) marker, creatine kinase-myocardial band (CK-MB), and ischemia-modified albumin. Traditional biomarker Tn levels may not rise immediately during ischemia, but MPO levels increase earlier, aiding early ACS detection. MPO, produced during inflammation, offers predictive data surpassing troponins. IMA also rises faster than troponins, signaling myocardial ischemia before irreversible damage. hs-CRP provides insights into inflammation and cardiovascular risk, complementing troponins. MicroRNAs serve as precise biomarkers for ACS, surpassing troponins in detecting molecular changes linked to the disease. These biomarkers enhance early diagnosis and treatment. Clinically, Tn levels may not have significantly risen at the early stage of ischemia; however, other biomarkers should be considered for early detection and risk stratification. Elevated MPO and IMA levels can indicate myocardial ischemia and inflammation earlier than troponins. hs-CRP offers additional insights into systemic inflammation and cardiovascular risk. MicroRNAs provide detailed molecular data and may outperform troponins in identifying ACS, offering a more sensitive diagnostic approach. Further monitoring and treatment adjustments based on these biomarkers are advised. In conclusion, while troponins remain crucial in diagnosing ACS, novel biomarkers like MPO, IMA, hs-CRP, and microRNAs offer earlier detection and better risk assessment. These markers provide additional insights into ischemia and inflammation, improving diagnostic accuracy and patient outcomes when used alongside traditional biomarkers.


  • Open Access

    Prevalence of depression and anxiety among chronic obstructive pulmonary disorder patients and its impact on the severity of the disease

    by B Kamini, Tt Gopinath, S Balamurugan, Jayakumar U Arun, Harish Narayanan

    Background: There is high prevalence of anxiety and depression in chronic obstructive pulmonary disease (COPD) patients, leading to habits such as smoking. Aims and Objectives: This study aims to relate quantitatively, the contribution of anxiety and depression on prognosis, smoking, and stage of the disease. Materials and Methods: This cross-sectional study was conducted over a period of 3 months on 50 male COPD patients, aged 40–70 years. Patients were recruited to participate in the study after obtaining informed consent and were administered a questionnaire. They were subjected for detailed clinical examination, chest-X ray. CAT, BODE, GOLD stage, MADRS, and HAM-A were calculated and submitted for statistical analysis. Results: Depression had more influence on smoking rather than anxiety. There was no contributing influence by age. Conclusion: Clinicians should be encouraged to concentrate more on addressing depression rather than anxiety.

  • MP20-16 TRAINING AND SKILLS ASSESSMENT FOR FUSION-GUIDED PROSTATE BIOPSY: DEFINING THE LEARNING CURVE

    by Akhil Muthigi, Arvin George, Daniel Su, Pingkun Yan, Jochen Kruecker, Harish Narayanan, Janice Thai, Meet Kadakia, Michael Kongnyuy, Amogh Iyer, et al.

    Advances in multiparametric MRI combined with improved sampling by MR/TRUS fusion-guided prostate biopsy (FBx) have resulted in rapid adoption of this novel technology into the biopsy paradigm. FBx accuracy is dependent on a number of factors and acquired skills that vary by user experience. We aim to define the differences among users with varying levels of experience with a tracked fusion biopsy platform.